Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francine Foss

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
American Journal of Hematology|June 16, 2011
Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphomaFrancine Foss, Madeleine Duvic, Elise A Olsen
Blood|April 7, 2005
A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphomaFrancine Foss, Marie France Demierre, Gina DiVenuti
Cancer Management and Research|December 29, 2010
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphomaFrederick Lansigan, Diane M Stearns, Francine Foss
Clinical Lymphoma|January 13, 2004
Denileukin diftitox and hyper-CVAD in the treatment of human T-cell lymphotropic virus 1-associated acute T-cell leukemia/lymphomaGina Di Venuti, Rangana Nawgiri, Francine Foss
Cellular Signalling|February 23, 2002
Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell linesLarry Cosenza, Gullu Gorgun, Alexander Urbano, et al.
Clinical Lymphoma & Myeloma|November 21, 2007
Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphomaTanya Hathaway, Antonio Subtil, Philip Kuo, et al.
Seminars in Oncology|March 7, 2006
Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptomsReinhard Dummer, Francine Foss, Brigitte Dreno, et al.
Expert Opinion on Drug Safety|July 16, 2019
A drug safety evaluation of mogamulizumab for the treatment of cutaneous T-Cell lymphomaSalma Afifi, Sara Mohamed, Jennifer Zhao, et al.
Expert Review of Anticancer Therapy|July 9, 2025
New nonchemotherapy treatment options for cutaneous T-cell lymphomas an updateTarsheen Sethi, Amrita Goyal-O'Leary, Suzanne Xu, et al.
British Journal of Haematology|May 14, 2021
How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndromeTarsheen K Sethi, Francesca Montanari, Francine Foss, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
American Journal of Hematology|June 16, 2011
Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphomaFrancine Foss, Madeleine Duvic, Elise A Olsen
Blood|April 7, 2005
A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphomaFrancine Foss, Marie France Demierre, Gina DiVenuti
Cancer Management and Research|December 29, 2010
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphomaFrederick Lansigan, Diane M Stearns, Francine Foss
Clinical Lymphoma|January 13, 2004
Denileukin diftitox and hyper-CVAD in the treatment of human T-cell lymphotropic virus 1-associated acute T-cell leukemia/lymphomaGina Di Venuti, Rangana Nawgiri, Francine Foss
Cellular Signalling|February 23, 2002
Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell linesLarry Cosenza, Gullu Gorgun, Alexander Urbano, et al.
Clinical Lymphoma & Myeloma|November 21, 2007
Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphomaTanya Hathaway, Antonio Subtil, Philip Kuo, et al.
Seminars in Oncology|March 7, 2006
Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptomsReinhard Dummer, Francine Foss, Brigitte Dreno, et al.
Expert Opinion on Drug Safety|July 16, 2019
A drug safety evaluation of mogamulizumab for the treatment of cutaneous T-Cell lymphomaSalma Afifi, Sara Mohamed, Jennifer Zhao, et al.
Expert Review of Anticancer Therapy|July 9, 2025
New nonchemotherapy treatment options for cutaneous T-cell lymphomas an updateTarsheen Sethi, Amrita Goyal-O'Leary, Suzanne Xu, et al.
British Journal of Haematology|May 14, 2021
How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndromeTarsheen K Sethi, Francesca Montanari, Francine Foss, et al.
Pageof 12